Scientific research ALCL

Additional information for physicians

• BI-ALCL Frequently Asked Questions--Resource For Physicians >>
• ALCL CME Module on PSEN >>
• FDA: Anaplastic Large Cell Lymphoma (ALCL) >>
• FDA Medical Device Reports of Breast Implants in Women with ALCL >

ALCL: Anaplastic Large-Cell lymphoma ( a Non-Hodgkin like disease / cancer)

Breast Implant-Associated Anaplastic Large Cell Lymphoma: What the Primary Care Physician Needs to Know 2020 >>

Breast Implant-Associated Anaplastic Large Cell Lymphoma in Australia: A Longitudinal Study of Implant and Other Related Risk Factors 2020 >>

Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Prospective Series of 52 Patients 2020 >>

Best Practices Guideline for the Pathologic Diagnosis of Breast Implant–Associated Anaplastic Large-Cell Lymphoma 2020 >>

Current Risk Estimate of Breast Implant–Associated Anaplastic Large Cell Lymphoma in Textured Breast Implants 2020 >>

Stepwise En Bloc Resection of Breast Implant-Associated Anaplastic Large Cell Lymphoma with Oncologic Considerations 2019 >>

Breast Implant–Associated Anaplastic Large Cell Lymphoma: What We Know 2019 >>

Synchronous Breast Implant–associated Anaplastic Large Cell Lymphoma and Invasive Carcinoma: Genomic Profiling and Management Implications 2019 >>

1st World Consensus Conference on BIA-ALCL. 6 okt. 2019 >>

The Epidemiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma in Australia and New Zealand Confirms the Highest Risk for Grade 4 Surface Breast Implants. mei 2019 >>

A Rare Case of a Transgender Female With Breast Implant–Associated Anaplastic Large Cell Lymphoma Treated With Radiotherapy and a Review of the Literature. mei 2019 >>

Microbial detection in seroma fluid preceding the diagnosis of breast implant-associated anaplastic large cell lymphoma: a case report and review of the literature. april 2019 >>

Stepwise En Bloc Resection of Breast Implant-Associated Anaplastic Large Cell Lymphoma with Oncologic Considerations febr 2019 >>

The First Reported Case of Gluteal Implant-Associated Anaplastic Large Cell Lymphoma (ALCL) febr 2019 >>

IL-13 is produced by tumor cells in Breast Implant Associated Anaplastic Large Cell Lymphoma: Implications for pathogenesis apr 2018 >>

Breast Implant-Associated Anaplastic Large Cell Lymphoma With Bone Marrow Involvement apr 2018 >>

Breast Implant-Associated Bilateral B-Cell Lymphoma apr 2018 >>

Breast implants and the risk of ALCL in the breast mrt 2018 >>

Breast Implant-Associated Lymphoma

The Diagnosis and Treatment of a New Disease Entity 2018 >>

Macrotextured Breast Implants with Defined Steps to Minimize Bacterial Contamination around the Device: Experience in 42,000 Implants. 2017 >>

Breast implant-associated anaplastic large cell lymphoma: A review and assessment of cutaneous manifestations juli 2017 >>

Breast Implant-Associated Anaplastic Large-Cell Lymphoma in a Transgender Woman juni 2017 >>

Axillaire disseminatie bij BIA-ALCL; waarom klinische awareness van belang is (NVPC okt. 2016) >>

Biomarkers Provide Clues to Early Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma 2016 >>

Breast Implant-Associated Anaplastic Large Cell Lymphoma: Two Distinct Clinicopathological Variants with Different Outcomes 2016 >>

Complete Surgical Excision is Essential for the Management of Patients with Breast Implant Associated Anaplastic Large-Cell Lymphoma

2016 >>

Breast Implant Informed Consent Should Include the Risk of Anaplastic Large Cell Lymphoma 2016 >>

The 2016 Revision of the World Health Organization Classification of Lymphoid Neoplasms 2016 >>

Bacterial Biofilm Infection Detected in Breast Implant–Associated Anaplastic Large-Cell Lymphoma juni 2016 >>

Breast Implant Informed Consent Should Include the Risk of Anaplastic Large Cell Lymphoma apr 2016 >>

Biomarkers Provide Clues to Early Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma. mrt 2016 >>

Bacterial biofilm infection detected in breast implant associated anaplastic large cell lymphoma febr. 2016 >>

Breast Implant Associated Anaplastic Large cell Lymphoma: two distinct clinicopathological variants with different outcomes nov. 2015 >>

Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant–Associated Anaplastic Large-Cell Lymphoma

2015 >>

Breast implant-associated anaplastic large-cell lymphoma. 2015 >>

The non-specific symptoms of breast implant-associated anaplastic large cell lymphoma resulting in delayed diagnosis: a case-based review 2015 >>

Breast Implant–associated Anaplastic Large Cell Lymphoma: updated results from a structured expert consultation process 2015 >>

Commentary on: Lymphomas Associated With Breast Implants: A Review of the Literature 2015 >>

Anaplastic Large Cell Lymphoma Occurring in Women with Breast Implants: Analysis of 173 Cases 2015 >>

Breast Implant-Associated Anaplastic Large Cell Lymphoma: Updated Results from a Structured Expert Consultation Process 2015 >>

Chronic Biofilm Infection in Breast Implants is Associated with an Increased T-Cell Lymphocytic Infiltrate: Implications for Breast Implant-Associated Lymphoma 2015 >>

Coming of Age Breast Implant-Associated Anaplastic Large Cell Lymphoma After18 Years of Investigation 2015 >>

Anaplastic large cell lymphoma (ALCL) and breast implants: Breaking down the evidence 2014 >>

Breast Implant-Associated Anaplastic Large Cell Lymphoma: Sensitivity, Specificity, and Findings of Imaging Studies in 44 Patients 2014>>

Breast implant-associated anaplastic large-cell lymphoma: long-term follow-up of 60 patients 2014 .>>

Breast Implant-Associated ALCL: A Unique Entity in the Spectrum of CD30 Lymphoproliferative Disorders 2014 >>

Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Systematic Review of the Literature and Mini-Meta Analysis 2013 >>

Breast implant associated ALK negative anaplastic large cell lymphoma; a case report and discussion of possible pathogenesis 2013 >>

Anaplastic large cell lymphoma occurring in association with breast implants: review of pathologic and immunohistochemical features in 103 cases. 2013 >>

Anaplastic lymphoma masquerading as breast abscess in a patient with silicone implants 2013 >>

Anaplastic large cell lymphoma and breast implants: five Australian cases. 2012 >>

Anaplastic Large Cell Lymphoma Associated With Breast Implants: A Report of 13 Cases 2012 >>

Anaplastic large cell lymphoma and breast implants 2011 >>

Managing Late Periprosthetic Fluid Collections (Seroma) in Patients with Breast Implants: A Consensus Panel Recommendation and Review of the Literature 2011 >>

A Patient Death Attributable to Implant-Related Primary Anaplastic Large Cell Lymphoma of the Breast 2011 >>

FDA; Anaplastic Large Cell Lymphoma (ALCL) In Women with Breast Implants: Preliminary FDA Findings and Analyses 2011 >>

Reaction 'Breast Cancer Action":

' BCA has long advocated that we must stop putting products in the marketplace before we fully understand their potential impact on human health.In this case, the studies that identified that women with breast implants have a small but increased risk of ALCL were conducted in post approval monitoring – after approved implants were surgically placed in women’s bodies. BCA will continue to urge the FDA to put patients first and have health data before approving medical devices.'

Primary breast lymphoma in a patient with silicone breast implants: a case report and review of the literature 2009 >>

Anaplastic large-cell lymphoma in women with breast implants 2008 >>

Seroma-associated primary anaplastic large-cell lymphoma adjacent to breast implants: an indolent T-cell lymphoproliferative disorder 2008 >>

Breast lymphoma associated with breast implants: two case-reports and a review of the literature 2002 >>